Soros Fund Management’s Abeona Therapeutics ABEO Stock Holding History

Soros Fund Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35,866	Closed	-$5.74M	–	229
2017 Q2	$5.74M	Hold	35,866	–	–	0.1%	89
2017 Q1	$4.48M	Hold	35,866	–	–	0.09%	106
2016 Q4	$4.35M	Sell	35,866 -22,619	-39%	-$3.54M	0.1%	101
2016 Q3	$8.77M	Hold	58,485	–	–	0.22%	76
2016 Q2	$3.45M	Hold	58,485	–	–	0.07%	96
2016 Q1	$3.74M	Hold	58,485	–	–	0.08%	113
2015 Q4	$4.91M	Hold	58,485	–	–	0.08%	128
2015 Q3	$5.92M	Buy	58,485 +21,818	+60%	+$2.9M	0.09%	139
2015 Q2	$4.64M	Buy	36,667 +26,667	+267%	+$4.01M	0.04%	175
2015 Q1	$785K	Hold	10,000	–	–	0.01%	206
2014 Q4	$875K	Buy	+10,000	New	+$897K	0.01%	173

Other funds holding ABEO

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Soros Fund Management's ABEO Position: Q3 2017 in Review

Soros Fund Management sold out of Abeona Therapeutics (ABEO) in Q3 2017, closing a stake of 35,866 shares — an estimated $5.74M sold.

Soros Fund Management first reported a position in ABEO in Q4 2014 and held it in 11 quarters. The position peaked at $8.77M in Q3 2016. 75 funds tracked by Wall St. Rank hold ABEO as of Q3 2017.

Soros Fund Management reported no remaining Abeona Therapeutics position as of Q3 2017 after selling out during the quarter.
Soros Fund Management sold 35,866 Abeona Therapeutics shares in Q3 2017, an estimated $5.74M.
Soros Fund Management first reported a position in Abeona Therapeutics in Q4 2014 and held it in 11 quarters.
Soros Fund Management's Abeona Therapeutics position peaked at $8.77M in Q3 2016.
75 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2017.

Based on Soros Fund Management's 13F filing for Q3 2017, filed 14 Nov 2017.